- Home
- ALRN vs JEQ Comparison
ALRN vs JEQ Comparison
Compare ALRN & JEQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALRN
- JEQ
- Stock Information
- Founded
- ALRN 2001
- JEQ 1990
- Country
- ALRN United States
- JEQ United States
- Employees
- ALRN N/A
- JEQ N/A
- Industry
- ALRN Biotechnology: Pharmaceutical Preparations
- JEQ Air Freight/Delivery Services
- Sector
- ALRN Health Care
- JEQ Consumer Discretionary
- Exchange
- ALRN Nasdaq
- JEQ Nasdaq
- Market Cap
- ALRN 76.9M
- JEQ 79.2M
- IPO Year
- ALRN 2017
- JEQ N/A
- Fundamental
- Price
- ALRN $1.97
- JEQ $5.66
- Analyst Decision
- ALRN Strong Buy
- JEQ
- Analyst Count
- ALRN 1
- JEQ 0
- Target Price
- ALRN $19.00
- JEQ N/A
- AVG Volume (30 Days)
- ALRN 137.2K
- JEQ 32.0K
- Earning Date
- ALRN 11-14-2024
- JEQ 01-01-0001
- Dividend Yield
- ALRN N/A
- JEQ 7.05%
- EPS Growth
- ALRN N/A
- JEQ N/A
- EPS
- ALRN N/A
- JEQ N/A
- Revenue
- ALRN N/A
- JEQ N/A
- Revenue This Year
- ALRN N/A
- JEQ N/A
- Revenue Next Year
- ALRN N/A
- JEQ N/A
- P/E Ratio
- ALRN N/A
- JEQ N/A
- Revenue Growth
- ALRN N/A
- JEQ N/A
- 52 Week Low
- ALRN $1.61
- JEQ $4.99
- 52 Week High
- ALRN $7.42
- JEQ $6.39
- Technical
- Relative Strength Index (RSI)
- ALRN 41.44
- JEQ 42.69
- Support Level
- ALRN $1.90
- JEQ $5.61
- Resistance Level
- ALRN $2.17
- JEQ $5.73
- Average True Range (ATR)
- ALRN 0.18
- JEQ 0.06
- MACD
- ALRN 0.02
- JEQ -0.01
- Stochastic Oscillator
- ALRN 23.27
- JEQ 25.93
About ALRN Aileron Therapeutics Inc.
Aileron Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on developing a novel class of therapeutics for the treatment of cancer and other diseases. The company's lead product candidate, ALRN-6924 is a novel chemoprotective medicine to treat and protect healthy cells in patients with cancer that harbors p53 mutations to reduce or eliminate chemotherapy-induced side effects. The company currently has two product candidates in clinical development, LTI-03 and LTI-01, and multiple candidates in preclinical development focused on fibrosis indications.
About JEQ abrdn Japan Equity Fund Inc.
Aberdeen Japan Equity Fund Inc is a United States-based closed-end diversified management investment company. Its investment objective is to outperform over the long term, on a total return basis (including appreciation and dividends), the Tokyo Stock Price Index ("TOPIX"). The fund seeks to achieve its investment objective by investing a majority of its assets, in equity securities of companies listed on the Tokyo Stock Exchange or listed on the over-the-counter market in Japan or listed on other stock exchanges in Japan. The portfolio of investments is spread across Consumer Discretionary, Industrials, Information Technology, Financials, and other sectors.